Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated CXL with Different Riboflavin Solutions
NCT03187912Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2016
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of riboflavin in keratoconus, sponsored by Medical University of Vienna. Started Sep 2016; status: completed.
02
Drugs
riboflavin
03
Conditions
keratoconus
Beyond the preview
Go deeper on NCT03187912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03187912.